Prevalence and characteristics of metabolic syndrome in 111 royal jordanian air force pilots

Aviation Space and Environmental Medicine

Volumn 78, Issue 10, 2007, Pages 968-972

  Khazale, Nawaf Salem ^a   Haddad, Fares ^a,b  

^a KING HUSSEIN MEDICAL CENTER   (Jordan)

^b NONE   (Jordan)

Author keywords

ATPIII criteria; Metabolic syndrome; Royal Jordanian Air Force

Indexed keywords

ALBUMIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POTASSIUM; SODIUM; THYROTROPIN; THYROXINE;

AIRPLANE PILOT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; JORDAN; KIDNEY FUNCTION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; STROKE; WAIST CIRCUMFERENCE;

ADULT; AGE FACTORS; AIRCRAFT; HUMANS; JORDAN; MALE; METABOLIC SYNDROME X; MILITARY PERSONNEL; PILOT PROJECTS; PREVALENCE; RISK FACTORS;

EID: 34848886096     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: 10.3357/ASEM.2097.2007     Document Type: Article

References (24)

1. Abdul-Ghani MA, Sabbah M, Muati B, Dakwar N, Kashkosh H, Minuchin O, et al. High frequency of pre-diabetes, undiagnosed diabetes and metabolic syndrome among overweight Arabs in Israel. Isr Med Assoc J 2005; 7:143-7.
2. Abdul-Rahim HF, Husseini A, Espen B, Giacaman R, Gordon N, Jervell J. The metabolic syndrome in the West Bank population. Diabetes Care 2001; 24:275-9.
3. Ajlouni K, Jaddou H, Batieha A. Obesity in Jordan. Int J Obes Relat Metab Disord 1998; 22:624-8.
4. Alberti KG, Zimmet PZ. For the WHO Consultation: Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: Diagnosis and classification of diabetes mellitus, provisional report of a WHO Consultation. Diabet Med 1998; 15:539-53.
5. Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care 2003; 26(6):1781-5.
6. Al-Nozha M, Al-Khadra A, Arafah MR, Al-Maatouq MA, Khalil MZ, Khan NB, et al. Metabolic syndrome in Saudi Arabia. Saudi Med J 2005; 26(12):1918-25.
7. Al-Qahtani DA, Imtiaz ML. Prevalence of metabolic syndrome in Saudi adult soldiers. Saudi Med J 2005; 26(9):1360-6.
8. Athyros VG, Bouloukos VI, Pehlivanidis AN, Papageorgiou AA, Dionysopoulou SG, Symeonidis AN, et al. The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study. Diabetes Obes Metab 2005; 7(4):397-405.
9. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004; 33:351-75.
10. Centers for Disease control and Prevention (CDC). Assessing risk factors for chronic disease-Jordan, 2004. MMWR Morb Mortal Wkly Rep 2006; 55:653-5.
11. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 2004; 89:108-13.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97.
13. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-9.
14. Gogia A, Agarwal PK. Metabolic syndrome. Indian J Med Sci 2006; 60(2):72-81.
15. Harzallah F, Alberti H, Ben Khalifa F. The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria. Diabet Med 2006; 23(4): 441-4.
16. Jaber LA, Brown MB, Hammad A, Zhu Q, Herman WH. The prevalence of the metabolic syndrome among Arab Americans. Diabetes Care 2004; 27(1):234-8.
17. Kompoti M, Mariolis A, Alevizos A, Kyrazis I, Protopsaltis I, Dimou E, et al. Elevated serum triglyceride is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes. [Abstract]. Cardiovasc Diabetol 2006; 5:21.
18. McNeill AM, Wayne DR, Girman CJ, Golden SH, Schmidt MI, East HE, et al. The Metabolic Syndrome and 11-Year Risk of Incident Cardiovascular Disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 2005; 28(2):385-90.
19. Ministry of Health National Committee's Report on Chronic Diseases in Jordan 2005. www.cdc.gov/mmwr/preview/mmwrhtml/ss5208a1.
20. Ozsahin AK, Gokcel A, Sezgin N, Akbaba M, Guvener N, Ozisik L, et al. Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr Metab 2004; 17(4):230-4.
21. Sorkhou EI, Al-Qallaf B, Al-Namash HA, Ben-Nakhi A, Al-Batish MM, Habiba SA. Prevalence of metabolic syndrome among hypertensive patients attending a primary care clinic in Kuwait. Med Princ Pract 2004; 13(1):39-42.
22. Soysal A, Demiral Y, Soysal D, Ucku R, Koseoglu M, Aksakoglu G. The prevalence of metabolic syndrome among young adults in Izmir, Turkey. Anadolu Kardiyol Derg 2005; 5(3):196-201.
23. Tillin T, Forouhi N, Johnston DG, McKeigue PM, Chaturvedi N, Godsland IF. Metabolic syndrome and coronary heart disease in South Asians, African-Caribbean and white Europeans: a UK population-based cross-sectional study. Diabetologia 2005; 48(4):649-56.
24. Vega GL. Obesity, the metabolic syndrome, and cardiovascular disease. Am Heart J 2001; 142:1108-16.